Feng Zhang

Prof. Feng Zhang

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2009 in Annual Review of Genomics and Human Genetics
Verified
Journal Article
Closed access
FZFeng Zhang
Feng Zhang
WGWenli Gu
Wenli Gu
MHMatthew E. Hurles
Matthew E. Hurles
JLJames Lupski
James Lupski
Copy number variation (CNV) is a source of genetic diversity in humans. Numerous CNVs are being identified with various genome analysis platforms, including array comparative genomic hybridization (aCGH), single nucleotide polymorphism (SNP) genotyping platforms, and next-generation sequencing. CNV formation occurs by both recombination-based and replication-based mechanisms and de novo locus-specific mutation rates appear much higher for CNVs than for SNPs. By various molecular mechanisms, including gene dosage, gene disruption, gene fusion, position effects, etc., CNVs can cause Mendelian or sporadic traits, or be associated with complex diseases. However, CNV can also represent benign polymorphic variants. CNVs, especially gene duplication and exon shuffling, can be a predominant mechanism driving gene and genome evolution.

1 April 2010 in New England Journal of Medicine
Verified
Journal Article
Open access
PDF file
JLJames R. Lupski
James R. Lupski
JRJeffrey G. Reid
Jeffrey G. Reid
CGClaudia Gonzaga-Jauregui
Claudia Gonzaga-Jauregui
DDDavid Rio Deiros
David Rio Deiros
DCDavid C.Y. Chen
David C.Y. Chen
RGRichard A. Gibbs
Richard A. Gibbs
Whole-genome sequencing may revolutionize medical diagnostics through rapid identification of alleles that cause disease. However, even in cases with simple patterns of inheritance and unambiguous diagnoses, the relationship between disease phenotypes and their corresponding genetic changes can be complicated. Comprehensive diagnostic assays must therefore identify all possible DNA changes in each haplotype and determine which are responsible for the underlying disorder. The high number of rare, heterogeneous mutations present in all humans and the paucity of known functional variants in more than 90% of annotated genes make this challenge particularly difficult. Thus, the identification of the molecular basis of a genetic disease by means of whole-genome sequencing has remained elusive. We therefore aimed to assess the usefulness of human whole-genome sequencing for genetic diagnosis in a patient with Charcot–Marie–Tooth disease. We identified a family with a recessive form of Charcot–Marie–Tooth disease for which the genetic basis had not been identified. We sequenced the whole genome of the proband, identified all potential functional variants in genes likely to be related to the disease, and genotyped these variants in the affected family members. We identified and validated compound, heterozygous, causative alleles in SH3TC2 (the SH3 domain and tetratricopeptide repeats 2 gene), involving two mutations, in the proband and in family members affected by Charcot–Marie–Tooth disease. Separate subclinical phenotypes segregated independently with each of the two mutations; heterozygous mutations confer susceptibility to neuropathy, including the carpal tunnel syndrome. As shown in this study of a family with Charcot–Marie–Tooth disease, whole-genome sequencing can identify clinically relevant variants and provide diagnostic information to inform the care of patients.

7 July 2015 in Human Molecular Genetics
Verified
Journal Article
Closed access
PDF file
FZFeng Zhang
Feng Zhang
JLJames Lupski
James Lupski
Genetic variants, including single-nucleotide variants (SNVs) and copy number variants (CNVs), in the non-coding regions of the human genome can play an important role in human traits and complex diseases. Most of the genome-wide association study (GWAS) signals map to non-coding regions and potentially point to non-coding variants, whereas their functional interpretation is challenging. In this review, we discuss the human non-coding variants and their contributions to human diseases in the following four parts. (i) Functional annotations of non-coding SNPs mapped by GWAS: we discuss recent progress revealing some of the molecular mechanisms for GWAS signals affecting gene function. (ii) Technical progress in interpretation of non-coding variants: we briefly describe some of the technologies for functional annotations of non-coding variants, including the methods for genome-wide mapping of chromatin interaction, computational tools for functional predictions and the new genome editing technologies useful for dissecting potential functional consequences of non-coding variants. (iii) Non-coding CNVs in human diseases: we review our emerging understanding the role of non-coding CNVs in human disease. (iv) Compound inheritance of large genomic deletions and non-coding variants: compound inheritance at a locus consisting of coding variants plus non-coding ones is described.

1 September 2011 in Cell
Verified
Journal Article
Closed access
PLPengfei Liu
Pengfei Liu
AEAyelet Erez
Ayelet Erez
SNSandesh C. Sreenath Nagamani
Sandesh C. Sreenath Nagamani
SDShweta U. Dhar
Shweta U. Dhar
KKKatarzyna E. Kołodziejska
Katarzyna E. Kołodziejska
WBWeimin Bi
Weimin Bi

21 June 2009 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
FZFeng Zhang
Feng Zhang
MKMehrdad Khajavi
Mehrdad Khajavi
ACAnne M. Connolly
Anne M. Connolly
CTCharles F Towne
Charles F Towne
SBSat Dev Batish
Sat Dev Batish
JLJames Lupski
James Lupski

1 September 2004 in Nature
Verified
Journal Article
Closed access
PDF file
BWBo Wen
Bo Wen
HLHui Li
Hui Li
DLDaru Lu
Daru Lu
XSXiufeng Song
Xiufeng Song
FZFeng Zhang
Feng Zhang
LJLi Jin
Li Jin